Surgery, Crohn's disease, and the biological era: Has there been an impact?

Journal of Clinical Gastroenterology

Volumn 45, Issue 8, 2011, Pages 691-693

  Slattery, Eoin ^a   Keegan, Denise ^a   Hyland, John ^a   O'donoghue, Diarmuid ^a   Mulcahy, Hugh E ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Crohn's disease; infliximab; resection

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; FEMALE; GROUPS BY AGE; HUMAN; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL TECHNIQUE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BIOLOGICAL THERAPY; CHILD; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; GASTROINTESTINAL AGENTS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOLOGIC FACTORS; IRELAND; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052027219     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318201ff96     Document Type: Article

References (8)

1. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-1549. (Pubitemid 34621118)
2. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340:1398-1405. (Pubitemid 29205403)
3. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350:876-85. (Pubitemid 38252535)
4. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg. 2000; 231:38-45. (Pubitemid 30043937)
5. Cosnes J, Nion-Larmurier I, Beaugerie L. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut. 2005;54:237-241. (Pubitemid 40139240)
6. LazarevM, Ullman T, SchrautWH. Small bowel resection rates and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis. 2010;16:830-835.
7. Schnitzler F, Fidder H, Ferrante M. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut. 2009;58:492-500.
8. Behm BW, Bickston SJ. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2008;23:CD006893.